Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Strieter

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
The American Journal of Pathology|October 9, 2002
The role of MIG/CXCL9 in cardiac allograft vasculopathyJames J Yun, Michael P Fischbein, David Whiting, et al.
Transplantation|October 27, 2004
Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantationDavid J Ross, Alexander M Cole, Dawn Yoshioka, et al.
International Journal of Cancer|May 12, 2009
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancerYoichi Matsuo, Massimo Raimondo, Timothy A Woodward, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejectionJohn A Belperio, Michael P Keane, Marie D Burdick, et al.
Cancer Research|September 2, 2008
Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironmentLi Zhong, Jonathon Roybal, Raghothama Chaerkady, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responsesSherven Sharma, Li Zhu, Seok Chul Yang, et al.
Oncoimmunology|July 3, 2015
GITR agonist enhances vaccination responses in lung cancerLi X Zhu, Michael Davoodi, Minu K Srivastava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Celecoxib decreases Ki-67 proliferative index in active smokersJenny T Mao, Michael C Fishbein, Bradley Adams, et al.
Cancer Research|December 17, 2005
Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesotheliomaArminder S Jassar, Eiji Suzuki, Veena Kapoor, et al.
Blood|October 29, 2010
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3Sofie Struyf, Laura Salogni, Marie D Burdick, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
The American Journal of Pathology|October 9, 2002
The role of MIG/CXCL9 in cardiac allograft vasculopathyJames J Yun, Michael P Fischbein, David Whiting, et al.
Transplantation|October 27, 2004
Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantationDavid J Ross, Alexander M Cole, Dawn Yoshioka, et al.
International Journal of Cancer|May 12, 2009
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancerYoichi Matsuo, Massimo Raimondo, Timothy A Woodward, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejectionJohn A Belperio, Michael P Keane, Marie D Burdick, et al.
Cancer Research|September 2, 2008
Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironmentLi Zhong, Jonathon Roybal, Raghothama Chaerkady, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responsesSherven Sharma, Li Zhu, Seok Chul Yang, et al.
Oncoimmunology|July 3, 2015
GITR agonist enhances vaccination responses in lung cancerLi X Zhu, Michael Davoodi, Minu K Srivastava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Celecoxib decreases Ki-67 proliferative index in active smokersJenny T Mao, Michael C Fishbein, Bradley Adams, et al.
Cancer Research|December 17, 2005
Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesotheliomaArminder S Jassar, Eiji Suzuki, Veena Kapoor, et al.
Blood|October 29, 2010
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3Sofie Struyf, Laura Salogni, Marie D Burdick, et al.
Pageof 18